CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 67 filers reported holding CULLINAN ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,797,840 | +139.1% | 217,766 | +133.6% | 0.00% | – |
| Q1 2024 | $1,588,503 | +76.5% | 93,222 | +5.5% | 0.00% | – |
| Q4 2023 | $900,012 | +26.5% | 88,323 | +12.3% | 0.00% | – |
| Q3 2023 | $711,475 | -14.5% | 78,616 | +1.7% | 0.00% | – |
| Q2 2023 | $831,866 | +112466.4% | 77,311 | +7.1% | 0.00% | – |
| Q1 2023 | $739 | -24.4% | 72,208 | -22.2% | 0.00% | – |
| Q4 2022 | $978 | -99.9% | 92,756 | -13.6% | 0.00% | -100.0% |
| Q3 2022 | $1,376,000 | +1.3% | 107,360 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $1,359,000 | -1.4% | 106,013 | -1.4% | 0.00% | – |
| Q1 2022 | $1,378,000 | -23.0% | 107,468 | -7.3% | 0.00% | -100.0% |
| Q4 2021 | $1,790,000 | -58.9% | 115,964 | -40.0% | 0.00% | 0.0% |
| Q3 2021 | $4,360,000 | +37.2% | 193,192 | +56.6% | 0.00% | 0.0% |
| Q2 2021 | $3,177,000 | +53.3% | 123,370 | +148.0% | 0.00% | 0.0% |
| Q1 2021 | $2,073,000 | – | 49,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |